100 related articles for article (PubMed ID: 19940031)
1. Presence and significance of a R110W mutation in the DNA-binding domain of GCM2 gene in patients with isolated hypoparathyroidism and their family members.
Tomar N; Bora H; Singh R; Gupta N; Kaur P; Chauhan SS; Sharma YD; Goswami R
Eur J Endocrinol; 2010 Feb; 162(2):407-21. PubMed ID: 19940031
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the GCM2 gene in isolated hypoparathyroidism: a molecular and biochemical study.
Maret A; Ding C; Kornfield SL; Levine MA
J Clin Endocrinol Metab; 2008 Apr; 93(4):1426-32. PubMed ID: 18182452
[TBL] [Abstract][Full Text] [Related]
3. Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders.
Canaff L; Guarnieri V; Kim Y; Wong BYL; Nolin-Lapalme A; Cole DEC; Minisola S; Eller-Vainicher C; Cetani F; Repaci A; Turchetti D; Corbetta S; Scillitani A; Goltzman D
Eur J Endocrinol; 2022 Feb; 186(3):351-366. PubMed ID: 35038313
[TBL] [Abstract][Full Text] [Related]
4. Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism.
Canaff L; Zhou X; Mosesova I; Cole DE; Hendy GN
Hum Mutat; 2009 Jan; 30(1):85-92. PubMed ID: 18712808
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of novel parathyroid-specific transcription factor Glial Cells Missing Homolog B (GCMB) mutations in eight families with autosomal recessive hypoparathyroidism.
Bowl MR; Mirczuk SM; Grigorieva IV; Piret SE; Cranston T; Southam L; Allgrove J; Bahl S; Brain C; Loughlin J; Mughal Z; Ryan F; Shaw N; Thakker YV; Tiosano D; Nesbit MA; Thakker RV
Hum Mol Genet; 2010 May; 19(10):2028-38. PubMed ID: 20190276
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of C106R, a novel mutation in the DNA-binding domain of GCMB, in a family with autosomal-dominant hypoparathyroidism.
Yi HS; Eom YS; Park IeB; Lee S; Hong S; Jüppner H; Mannstadt M; Lee S
Clin Endocrinol (Oxf); 2012 May; 76(5):625-33. PubMed ID: 22066718
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation in the GCM2 gene causing severe congenital isolated hypoparathyroidism.
Doyle D; Kirwin SM; Sol-Church K; Levine MA
J Pediatr Endocrinol Metab; 2012; 25(7-8):741-6. PubMed ID: 23155703
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive next-generation sequencing analyses of hypoparathyroidism: identification of novel GCM2 mutations.
Mitsui T; Narumi S; Inokuchi M; Nagasaki K; Nakazawa M; Sasaki G; Hasegawa T
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2421-8. PubMed ID: 25137426
[TBL] [Abstract][Full Text] [Related]
9. A missense glial cells missing homolog B (GCMB) mutation, Asn502His, causes autosomal dominant hypoparathyroidism.
Mirczuk SM; Bowl MR; Nesbit MA; Cranston T; Fratter C; Allgrove J; Brain C; Thakker RV
J Clin Endocrinol Metab; 2010 Jul; 95(7):3512-6. PubMed ID: 20463099
[TBL] [Abstract][Full Text] [Related]
10. Autosomal Dominant PTH Gene Signal Sequence Mutation in a Family With Familial Isolated Hypoparathyroidism.
Cinque L; Sparaneo A; Penta L; Mencarelli A; Rogaia D; Esposito S; Fabrizio FP; Baorda F; Verrotti A; Falorni A; Stangoni G; Hendy GN; Guarnieri V; Prontera P
J Clin Endocrinol Metab; 2017 Nov; 102(11):3961-3969. PubMed ID: 28938448
[TBL] [Abstract][Full Text] [Related]
11. Five patients with disorders of calcium metabolism presented with GCM2 gene variants.
García-Castaño A; Madariaga L; Gómez-Conde S; Cordo CLR; López-Iglesias M; Garcia-Fernández Y; Martín A; González P; Goicolea I; de Nanclares GP; De la Hoz AB; Aguayo A; de LaPiscina IM; Martínez R; Saso L; Urrutia I; Velasco O; Castaño L; Gaztambide S
Sci Rep; 2021 Feb; 11(1):2968. PubMed ID: 33536578
[TBL] [Abstract][Full Text] [Related]
12. Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB.
Ding C; Buckingham B; Levine MA
J Clin Invest; 2001 Oct; 108(8):1215-20. PubMed ID: 11602629
[TBL] [Abstract][Full Text] [Related]
13. Familial hypoparathyroidism: identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor.
Watanabe T; Bai M; Lane CR; Matsumoto S; Minamitani K; Minagawa M; Niimi H; Brown EM; Yasuda T
J Clin Endocrinol Metab; 1998 Jul; 83(7):2497-502. PubMed ID: 9661634
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel mutation disrupting the DNA binding activity of GCM2 in autosomal recessive familial isolated hypoparathyroidism.
Baumber L; Tufarelli C; Patel S; King P; Johnson CA; Maher ER; Trembath RC
J Med Genet; 2005 May; 42(5):443-8. PubMed ID: 15863676
[No Abstract] [Full Text] [Related]
15. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
[TBL] [Abstract][Full Text] [Related]
16. Genetic and clinical characteristics of korean patients with isolated hypoparathyroidism: from the Korean hypopara registry study.
Park SY; Eom YS; Choi B; Yi HS; Yu SH; Lee K; Jin HS; Chung YS; Jung TS; Lee S
J Korean Med Sci; 2013 Oct; 28(10):1489-95. PubMed ID: 24133354
[TBL] [Abstract][Full Text] [Related]
17. A common structural mechanism underlying GCMB mutations that cause hypoparathyroidism.
Sticht H; Hashemolhosseini S
Med Hypotheses; 2006; 67(3):482-7. PubMed ID: 16697534
[TBL] [Abstract][Full Text] [Related]
18. Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2.
Grigorieva IV; Mirczuk S; Gaynor KU; Nesbit MA; Grigorieva EF; Wei Q; Ali A; Fairclough RJ; Stacey JM; Stechman MJ; Mihai R; Kurek D; Fraser WD; Hough T; Condie BG; Manley N; Grosveld F; Thakker RV
J Clin Invest; 2010 Jun; 120(6):2144-55. PubMed ID: 20484821
[TBL] [Abstract][Full Text] [Related]
19. Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohorts.
D'Agruma L; Coco M; Guarnieri V; Battista C; Canaff L; Salcuni AS; Corbetta S; Cetani F; Minisola S; Chiodini I; Eller-Vainicher C; Spada A; Marcocci C; Guglielmi G; Zini M; Clemente R; Wong BY; de Martino D; Scillitani A; Hendy GN; Cole DE
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2794-8. PubMed ID: 25279501
[TBL] [Abstract][Full Text] [Related]
20. GCMB mutation in familial isolated hypoparathyroidism with residual secretion of parathyroid hormone.
Thomée C; Schubert SW; Parma J; Lê PQ; Hashemolhosseini S; Wegner M; Abramowicz MJ
J Clin Endocrinol Metab; 2005 May; 90(5):2487-92. PubMed ID: 15728199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
